Published January 2016 | Version v1
Journal article Metadata-only

Survival benefit from the addition of bevacizumab to first-line radiochemotherapy for the treatment of proneural glioblastoma?

Creators

  • 1. Universitaetsklinikum Leipzig, Leipzig (Germany)

Description

no abstract available

Availability note (English)

Available from: http://dx.doi.org/10.1007/s00066-015-0922-3

Additional details

Additional titles

Original title (German)
Ueberlebensvorteil durch Kombination von Bevacizumab mit konventioneller Radiochemotherapie bei Glioblastomen vom proneuralen Subtyp

Identifiers

DOI
10.1007/s00066-015-0922-3;

Publishing Information

Journal Title
Strahlentherapie und Onkologie
Journal Volume
192
Journal Issue
1
Journal Page Range
p. 65-66
ISSN
0179-7158
CODEN
STONE4

INIS

Country of Publication
Germany
Country of Input or Organization
Germany
INIS RN
47024376
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Resource subtype / Literary indicator
No Abstract
Descriptors DEI
AGE DEPENDENCE; ANGIOGENESIS; CHEMOTHERAPY; CLASSIFICATION; COMBINED THERAPY; GENETICS; GLIOMAS; MULTIVARIATE ANALYSIS; RADIOTHERAPY; SEX DEPENDENCE; SURVIVAL CURVES; SURVIVAL TIME
Descriptors DEC
BIOLOGY; DISEASES; MATHEMATICS; MEDICINE; NEOPLASMS; NERVOUS SYSTEM DISEASES; NUCLEAR MEDICINE; RADIOLOGY; STATISTICS; THERAPY